Clinical Trials Logo

Clinical Trial Summary

EpiBone-Craniomaxillofacial (EB-CMF) is an autologous, anatomically shaped bone graft created specifically for the patient's defect, using the patients own adipose-derived mesenchymal stem cells. This first in human trial is designed specifically to assess the safety of EB-CMF clinically. Although secondary measures of graft efficacy are being assessed, the primary focus will be on Adverse Events stemming from graft implantation.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03678467
Study type Interventional
Source Epibone, Inc.
Contact Brian R Gastman, MD
Phone 216-444-9419
Email gastmab@ccf.org
Status Recruiting
Phase Phase 1/Phase 2
Start date March 31, 2021
Completion date November 2023

See also
  Status Clinical Trial Phase
Terminated NCT01834339 - EVPOME Versus AlloDerm in Subjects Reconstructed With Large Defect Mandibular Resection Phase 2
Completed NCT03054012 - Accuracy and Outcome of Computer-assisted Surgery for Bony Micro-vascular Reconstruction in the Head and Neck Region
Completed NCT00628849 - Champy Versus AO for Mandible Fractures N/A